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Vernonia amygdalina is a plant with great medicinal potentials due to the phytochemicals it possesses. The 
establishment of axenic culture and callus induction are important as the primary steps to acquire callus and cell 
suspension cultures which are prospective to be used as alternatives in the production of phytochemicals. The 
effect of different regimes of sterilization unveiled that explants treated with mercuric chloride showed 
significant difference in the mean number of axenic explants, but observations of serious necrosis in all explants 
that later lead to death were recorded. Whilst, the explants treated with Clorox® were not significantly difference 
in the mean number of axenic explants but the explants obtained were healthy and the growth was sustained. For 
callus induction, there was no significant difference in the callus induction frequency (CIF) among different 
concentrations of 2,4-D or picloram. In conclusions, the explants were recommended to be surface sterilized 
with 15% of Clorox® for 15 minutes as it was more economical and less time consuming. Whereas, MS media   
supplemented with 0.5 mg/L 2,4-D or 0.5 mg/L picloram would be a better choice for callus induction due to 
observation of root formation at lower concentrations of 2,4-D.  




Bitter leaf or scientifically known as Vernonia 
amygdalina Del. is a small tree or shrub that 
belongs to the family Asteraceae (Fomum, 
2004; Ofori et al., 2013). Vernonia genus has a 
total of 109 species being reported to have 
medicinal properties. The most commonly used 
species is V. amygdalina (Toyang & Verpoorte, 
2013). The leaf of V. amygdalina has been used 
as traditional medicine to treat fever, malaria, 
dysentery, hepatitis, diarrhea as well as cough. 
Also, the leaves are used to treat headache, 
stomachache, scabies, malaria and 
gastrointestinal disorders (Fomum, 2004). 
Secondary metabolites or phytochemicals 
possess in V. amygdalina are the one that is 
responsible for pharmacologic activities such as 
hypoglycaemic, hypolipidemic, antimalarial, 
antioxidant and anti-inflammatory activities 
(Audu et al., 2012). The major bioactive 
compounds of V. amygdalina are sesquiterpene 
lactones and stigmastane-type steroid glucoside 
compounds (Yeap et al., 2010). 
    However, bitter leaf with great medicinal 
potentials is grown for personal needs rather 
than  for  commercial purposes.  The  processed 
  
leaves of V. amygdalina are sold at high price as 
compared to raw commodity in Cameroon. 
Conventional propagation of V. amygdalina is 
commonly by rooting of stem cuttings where 
mature stems are selected while seeds are also 
used (Fomum, 2004). Propagation is plausible 
by using seeds collected from dry flower heads 
but stem cuttings are used in general due to 
faster growth (Ofori et al., 2013). In spite of 
conventional propagation, studies shown that in 
vitro micropropagation played a key role in 
clonal propagation of elite genotypes of V. 
amygdalina for the production of secondary 
metabolites that are valuable by pharmaceutical 
means (Khalafalla et al., 2007).  
    Plant cell culture is promising potential 
alternative sources to produce secondary 
metabolites at commercial scale (Rao & 
Ravishankar, 2002). There are reports on the 
production of phytochemicals in both 
suspension and callus cultures. Some secondary 
metabolites     are     produced     in higher 
concentrations in cultured cells as compared to 
the whole plants of the same species (Linden, 
2002). On top of that, plant cell culture makes 
great strides for the production of 
pharmaceuticals  and  chemicals as the synthesis    
